Edition:
United Kingdom

People: Cytokinetics Inc (CYTK.OQ)

CYTK.OQ on NASDAQ Stock Exchange Global Select Market

8.47USD
22 Apr 2019
Change (% chg)

$0.39 (+4.83%)
Prev Close
$8.08
Open
$8.08
Day's High
$8.50
Day's Low
$8.05
Volume
100,145
Avg. Vol
145,794
52-wk High
$10.42
52-wk Low
$5.76

Gage, Leonard Patrick 

Dr. Leonard Patrick Gage, Ph.D., is Independent Chairman of the Board of the Company. Dr. Gage has served as a consultant to the biopharmaceutical industry, including serving as an advisor to venture capital firms. From 1998 to 2002, Dr. Gage was President of Wyeth Research and subsequently also Senior Vice President, Science and Technology for American Home Products, parent company of Wyeth Research. From 1989 to 1998, he held roles of increasing responsibility at Genetics Institute, Inc., first as head of Research and Development, then as Chief Operating Officer and eventually as President. From 1971 to 1989, Dr. Gage held various positions in research management with Hoffmann-La Roche Inc., most recently serving as Vice President responsible for U.S. drug discovery. Dr. Gage has served as the Chairman of the Board of Directors of Tetraphase Pharmaceuticals since April 2013. Dr. Gage earned a bachelor’s degree in Physics from the Massachusetts Institute of Technology and a Ph.D. in Biophysics from the University of Chicago.

Basic Compensation

Total Annual Compensation, USD 100,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 191,926
Fiscal Year Total, USD 291,926

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leonard Patrick Gage

291,926

Robert Blum

2,867,840

Ching Jaw

1,099,890

Fady Malik

1,219,940

Peter Roddy

--

David Cragg

388,209
As Of  31 Dec 2017